Use of indomethacin to minimize the adverse reactions associated with orthoclone OKT3 treatment of kidney allograft rejection.
Shield
C F
CF
St. Francis Regional Medical Center, Raritan, NJ.
Kahana
L
L
Pirsch
J
J
Vergne-Marini
P
P
First
M R
MR
Schroeder
T J
TJ
Cohen
D
D
Norman
D J
DJ
Monaco
A
A
Martinez
A
A
D000328:Adult; D016207:Cytokines / Q000096:biosynthesis; D005260:Female; D006084:Graft Rejection; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000009:adverse effects*; D014184:Transplantation, Homologous
D016207:Cytokines; D016853:Muromonab-CD3; D007213:Indomethacin